Nupercaine
Brand names,
Nupercaine
Analogs
Nupercaine
Brand Names Mixture
Nupercaine
Chemical_Formula
C21H27NO
Nupercaine
RX_link
No information avaliable
Nupercaine
fda sheet
Nupercaine
msds (material safety sheet)
Nupercaine
Synthesis Reference
No information avaliable
Nupercaine
Molecular Weight
309.445 g/mol
Nupercaine
Melting Point
No information avaliable
Nupercaine
H2O Solubility
No information avaliable
Nupercaine
State
Solid
Nupercaine
LogP
4.86
Nupercaine
Dosage Forms
Tablets for oral administration (25 mg, 50 mg)
Nupercaine
Indication
For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.
Nupercaine
Pharmacology
No information avaliable
Nupercaine
Absorption
Well absorbed from gastrointestinal tract following oral administration.
Nupercaine
side effects and Toxicity
Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).
Nupercaine
Patient Information
No information avaliable
Nupercaine
Organisms Affected
Humans and other mammals